Lauren Davey
Has grant
Assistant Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Open
Modulation of the intestinal bacterium Akkermansia muciniphila to enhance healthy aging and longevity
Open Date: 2024-10-01
Close Date: 2027-09-30
Grant: Open
Mucus-degrading intestinal bacteria and toxicities of hematopoietic cell transplantation
Open Date: 2024-09-21
Close Date: 2029-07-31
Grant: Close
Genetic Dissection of Nutrient Acquisition in Diverse Akkermansia Strains
Open Date: 2022-04-01
Close Date: 2023-03-31
Grant: Close
Investigation of disulfide bond formation in Streptococcus pyogenes
Open Date: 2018-04-01
Close Date: 2019-03-31
Grant: Close
Effect of Pseudomonas aeruginosa elastase on Listeria biofilms
Open Date: 2010-04-01
Close Date: 2011-03-31
Articles (11)
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Akkermansia muciniphila , an obligate mucin degrader, is a major member of the human colonic microbiota and has been associated positive health outcomes. Mucins are complex glycoproteins that contain heavily sulfated O -glycans and form the protective colonic mucus layer. Bacterial carbohydrate sulfatases are required to metabolise these heavily sulfated mucin glycans and excessive bacterial foraging has been associated with several diseases. Sulfatases have been linked with inflammatory bowel disease, making these microbiota enzymes potential drug targets. A. muciniphila expresses carbohydrate sulfatases that can act on colonic mucins yet their roles in its metabolism remain opaque. Our data reveal that A. muciniphila requires glycopeptides/protein forms of colonic mucin for metabolism and its sulfatases have unique adaptations compared to Bacteroides species. Localisation studies reveal that desulfation of N -acetyl-D-glucosamine, but not D-galactose, is exclusively periplasmic. A cell surface sulfatase has a novel carbohydrate binding module that binds to colonic mucin. This paints a contrasting picture of sulfated mucin metabolism by Akkermansia muciniphila versus Bacteroides species. These data will be important for understanding the contexts for Akkermansia muciniphila ’s positive health correlations.
Year:
2025
Aim: Akkermansia are common members of the human gastrointestinal microbiota. The prevalence of these mucophilic bacteria, especially Akkermansia muciniphila (A. muciniphila ), correlates with immunological and metabolic health. The genus Akkermansia in humans includes species with significantly larger genomes than A. muciniphila , leading us to postulate that this added genetic content may influence how they impact human metabolic and immunological health. Methods: We conducted a pangenomic analysis of 234 Akkermansia complete or near-complete genomes. We also used high-resolution species and subspecies assignments to reanalyze publicly available metagenomic datasets to determine if there are relationships between Akkermansia species and A. muciniphila clades with various disease outcomes. Results: Analysis of genome-wide average nucleotide identity, 16S rRNA gene identity, conservation of core Akkermansia genes, and analysis of the fatty acid composition of representative isolates support the partitioning of the genus Akkermansia into several species. In addition, A. muciniphila sensu stricto , the most prevalent Akkermansia species in humans, should be subdivided into two subspecies. For a pediatric cohort, we observed species-specific correlations between Akkermansia abundance with baseline obesity or after various interventions. For inflammatory bowel disease cohorts, we identified a decreased abundance of Akkermansia in patients with ulcerative colitis or Crohn’s disease, which was species and subspecies-dependent. In patients undergoing immune checkpoint inhibitor therapies for non-small cell lung carcinoma, we observed a significant association between one A. muciniphila subspecies and survival outcomes. Conclusion: Our findings suggest that the prevalence of specific Akkermansia species and/or subspecies can be crucial in evaluating their association with human health, particularly in different disease contexts, and is an important consideration for their use as probiotics.
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Collaborators (11)
Alan Cartmell
Senior Lecturer
University of Liverpool
Helena Petrosova
Assistant Professor
University of Victoria
Sjoerd van der Post
Göteborgs Universitet
Daniel J. Rigden
Personal Chair
University of Liverpool
Debajit Dey
University of Leeds
David Robinson Goodlett
Professor and Proteome Centre Director
University of Victoria
Lawrence David
Assistant Professor
Duke University School of Medicine
E. A. Yates
Reader
University of Liverpool
Gang Fang
Professor
Icahn School of Medicine at Mount Sinai
Christoph George Baumann
Lecturer in Molecular Biophysics
University of York
Maria Emilia Panzetta
Research Associate Sr
Duke University
Make your next move.
Prepare your application
Review drafts before you send them.